))
Cancer HealthCast: This AI Tool Could Predict a Patient's Response to Immunotherapy
Manage episode 425467493 series 3559856
Innhold levert av GovCIO Media & Research and GovCIO Media. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av GovCIO Media & Research and GovCIO Media eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Artificial Intelligence is impacting two main areas of cancer research: image analysis and managing massive amounts of clinical data. The National Cancer Institute sees AI as a key capability in precision oncology.
Dr. Eytan Ruppin, chief of NCI’s Cancer Data Science Lab, recently published a study about a new AI tool researchers are implementing to foresee how a patient will respond to immunotherapy by providing an in-depth look at the clinical characteristics of the patient as well as the Tumor Mutational Burden (TMB).
Ruppin discusses the NCI/CCR Synthesis Clinical Trial expected to start this fall and shares details about how the research will impact the treatment of aggressive breast cancer.
248 episoder
Del
